Editas Medicine, Inc. (EDIT)

NASDAQ: EDIT · USD

$2.94

+0.34 (+13.1%)· Recorded snapshot

Market cap	451.5M
Revenue (ttm)	47M
Net income (ttm)	-73.9M
EPS (ttm)	-$0.73
Shares out	153.6M
Volume	4,099,078
Beta	2.00

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 47M
Net income (ttm): -73.9M
EPS (ttm): -$0.73
Market cap: 451.5M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Держать

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-118.8

P25 n/aP50 n/aP75 n/a

ROIC-64.8

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All EDIT indicators

Market & fundamental data

Available fields

208

Groups with data

Currency

USD

Showing 208 of 208 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001650664
Company name	Editas Medicine, Inc.
Country	United States
Country code	US
CUSIP number	28106W103
Earnings date	2026-11-09
Earnings time	bmo
Employees	87
Employees change	-159
Employees growth	-64.63%
Enterprise value	$255.4M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2013
In index	RUSSELL2000
Industry	Biotechnology
IPO date	2016-02-03
Is primary listing	Yes
Is SPAC	No
ISIN number	US28106W1036
Last 10-K release date	2026-03-09
Last earnings date	2026-08-05
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$451.5M
Market cap category	Small-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$2.94
Price currency	USD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	EDIT
U.S. state	Massachusetts
Website	https://www.editasmedicine.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-24.85%
EV/Sales	4.68x
FCF / EV yield	-54.78%
FCF yield	-28.96%
Forward EV/Sales	12.69x
Forward P/S	23.99x
P/B ratio	3.79x
P/S ratio	8.85x
Price / tangible book value	3.95x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-177.56%
EBITDA margin	-172.4%
Gross margin	-80.74%
Operating margin	-177.56%
Pretax margin	-157.32%
Profit margin	-157.32%
Profit per employee	$-849,989
Revenue per employee	$540,287
ROA	-23.29%
ROA (5Y)	-24.58%
ROCE	-49.41%
ROE	-118.82%
ROE (5Y)	-85.66%
ROIC	-64.75%
SBC / revenue	18.41%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	2
EPS growth years	1
Net income growth quarters	5
Net income growth years	1
Revenue growth	20.83%
Revenue growth (Q)	232.31%
Revenue growth (QoQ)	319.99%
Revenue growth 10Y	23.59%
Revenue growth 3Y	34.51%
Revenue growth 5Y	-10.34%
Revenue growth quarters	1
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-691,000
Depreciation and amortization	$2.4M
EBIT	$-83.5M
EBITDA	$-81M
EPS	$-0.73
FCF per share	$-0.78
Financing cash flow	$152M
Free cash flow	$-120.6M
Free cash flow minus SBC	$-129.2M
Gross profit	$-38M
Investing cash flow	$9.9M
Net cash flow	$42.1M
Net income	$-73.9M
Operating cash flow minus SBC	$-128.5M
Operating income	$-83.5M
Revenue	$47M
Stock-based compensation	$8.7M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-8.85
Book value per share	$0.69
Debt / equity	0.15
Interest coverage	-20.52
Long-term assets	$19.3M
Long-term liabilities	$63.6M
Net cash (debt)	$196.1M
Net cash / market cap	47.12%
Net cash growth	24.64%
Net debt / equity	-1.86
Piotroski F-Score	3
Property, plant and equipment	$16.3M
Shareholders' equity	$105.3M
Tangible book value	$105.3M
Tangible book value per share	$0.69
Total assets	$237.4M
Total cash	$211.6M
Total debt	$15.5M
Total liabilities	$132.1M
WACC	15.44%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.21
Current assets	$218.1M
Current liabilities	$68.4M
Current ratio	3.19
Net working capital	$-55.5M
Quick ratio	3.13
Working capital	$149.6M
Working capital turnover	0.35

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-21.72%
Dividend yield	0%
Shareholder yield	-21.72%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-78.21%
10Y return CAGR	-14.14%
10Y total return	-78.21%
150-day SMA	$2.87
1D price change	13.08%
1M price change	11.63%
1M total return	11.63%
1W price change	11.63%
1W total return	11.63%
1Y price change	-11.38%
1Y return CAGR	-11.39%
1Y total return	-11.38%
20-day SMA	$2.59
200-day SMA	$2.68
3M price change	7.46%
3M total return	7.46%
3Y price change	-53.99%
3Y return CAGR	-22.8%
3Y total return	-53.99%
50-day SMA	$2.77
50-day SMA vs 200-day SMA	50over200
52-week high	$3.94
52-week high date	2026-05-27
52-week low	$1.66
52-week low date	2026-02-05
5Y price change	-92.17%
5Y return CAGR	-39.93%
5Y total return	-92.17%
6M price change	-0.35%
6M total return	-0.35%
All-time high	$99.95
All-time high date	2021-01-08
All-time low	$0.91
All-time low date	2025-04-07
Average true range (ATR)	$0.20
Average volume	2.4M
Beta (1Y)	3.11
Beta (2Y)	2.64
Beta (5Y)	2
Change from 52-week high	-25.38%
Change from 52-week low	77.11%
Change from all-time high	-97.12%
Change from all-time low	216.45%
Change from open	13.73%
Day's gap	-0.58%
Dollar volume	$12.1M
High price	$2.96
Low price	$2.59
Monthly RSI	45.31
Open price	$2.59
Position in 52-week range	95.95%
Premarket change	0.65%
Premarket close	$2.60
Premarket price	$2.62
Premarket volume	23.3K
Previous close	$2.60
Price vs 150-day SMA	2.62%
Price vs 20-day SMA	13.65%
Price vs 200-day SMA	9.91%
Price vs 50-day SMA	6.1%
Relative volume	1.77
RSI	60.16
Sharpe ratio	0.23
Sharpe ratio (3Y)	0.19
Sharpe ratio (5Y)	-0.15
Sortino ratio	0.43
Sortino ratio (3Y)	0.39
Sortino ratio (5Y)	-0.18
Volume	4.1M
Weekly RSI	53.03
YTD price change	40.49%
YTD total return	40.49%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	115.5M
Float percentage	75.2%
Shares change (QoQ)	21.88%
Shares change (YoY)	21.72%
Shares held by insiders	0.2%
Shares held by institutions	54.13%
Shares outstanding	153.6M
Short % of float	32.13%
Short % of shares	24.16%
Short ratio	12.5 days

Deeper analysis on EDIT

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this EDIT report

Is a complete EDIT research report available?

No complete published report is available for Editas Medicine, Inc. (EDIT) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Editas Medicine, Inc. (EDIT)

Price

Financial snapshot

Fair-value bridge

Latest news · EDIT

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All EDIT indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on EDIT

Frequently asked questions